BIOGRAPHY
George is a medical oncologist in Auckland. Many
years ago he was an internal medicine trainee in Wellington. In the interim he
studied health economics and tumour physiology in London and Manchester. These
days his practice is mainly in respiratory malignancy and sarcomas, including
adolescent and young adult cancer. Ki te taha a tona Māmā, he uri a Te
Whakatōhea a Hōri. George chairs the Māori Health Committee of the RACP,
and is a member of its NZ Committee, and of the College Policy and Advocacy
Council and its Advisory Committee. He chairs the College’s Working Party on
Euthanasia and Physician Assisted Dying. In his spare time he enjoys
going out to see a band, and a long bike ride.
ABSTRACT
Euthanasia
And Physician Assist Dying
Euthanasia and Physician Assisted Dying (EPAD) is a live political
topic in New Zealand and Australia. The plus side is that it has got
society to think and talk about death and dying. The down side is that
the conversations can be charged and divisive. In New Zealand, the RACP’s
NZ Committee recently submitted to the parliamentary inquiry of the Health
Select Committee. We made three main points: (1) it is complex, (2) it is
a topic of significant importance to physicians caring for their patients, and
(3) physicians need to be involved in any developments. At the
trans-Tasman level, the College set up a Working Party to clarify its position.
Although mindful of strong views in either direction, there is an
over-riding awareness of the need to contribute to informed and respectful
dialogue. How should physicians respond to externally-driven change in
their ethical working environment? How should physicians respond in the
event that EPAD becomes legislated? This presentation will update on the
Working Party’s thinking and progress.
Update
On Electronic Cigarettes
The modern electronic cigarette was patented by Chinese pharmacist Hon Lik
in 2003, to start with as a personal effort to stop smoking. It consists of
three main parts: a battery, a vaporiser, and a cartridge. The cartridge is
loaded with “e-liquid”, that is aerosolised and inhaled. E-liquids are composed
of propylene glycol, glycerol, and optionally, nicotine and flavourings. The
practice of “vaping” has developed a profitable global following. Sales
exceeded $6Bn US in 2015 — still less than 1% of total tobacco sales, but
expected to reach $32Bn by 2021. The e-cigarette is a topic of controversy in
public health. Opponents perceive a threat to the tobacco endgame, and an
attempt by the tobacco industry to re-mormalise smoking and recruit a new
generation of nicotine addicts. Supporters perceive a possible safe and
effective new form of inhaled nicotine replacement, and appeal to civil
liberties. Evidence on the risks and benefits has lagged behind opinion. It
seems the e-cigarette has to some extent fractured an alliance between those
more opposed to the addictive nature of tobacco smoking in populations, and
those more concerned with its effects on the health of individuals. This
presentation will review the current and future status of e-cigarette technology
and regulation.